Back to Stakeholders

Optimi HealthCSE: OPTI

1 Trial

Canadian GMP-certified manufacturer of pharmaceutical-grade psilocybin and MDMA, licensed by Health Canada. Optimi's facility in Princeton, British Columbia is one of the largest legal psilocybin production operations in North America. Supplies clinical trial material to researchers in Australia, Israel, and Canada.

Quick Facts

Type
Public Biotech
Ticker
CSE: OPTI
Website
Visit

Sponsored Trials

1